World's Best Scientists 2026 revealed!
Richard B. Kennedy

Richard B. Kennedy

D-Index & Metrics

Immunology

D-Index
51
Citations
8747
World Ranking
4157
National Ranking
1896

Research.com Recognitions

  • 1966 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Richard B. Kennedy is affiliated with the Mayo Clinic in the United States. Their research spans several areas within medicine, focusing especially on infectious diseases and immunology. The scientist has produced a substantial body of work, contributing to fields such as medicine, immunology and microbiology, and subfields including infectious diseases, epidemiology, immunology, molecular biology, and health.

The main topics of study covered in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Vaccines and immunoinformatics approaches
  • Virology and Viral Diseases
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • Immune responses and vaccinations

Among the recent papers associated with Richard B. Kennedy are:

  • SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates, 2020, The Lancet
  • The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity, 2020, Immunological Reviews
  • Prevention of monkeypox with vaccines: a rapid review, 2022, The Lancet Infectious Diseases
  • Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice, 2022, Science Translational Medicine
  • Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations, 2021, Scientific Reports

Richard B. Kennedy frequently collaborates with several researchers, including:

  • Inna G. Ovsyannikova
  • Gregory A. Poland
  • Iana H. Haralambieva
  • Diane E. Grill
  • Huy Quang Quach

The venues where this scientist most often publishes include:

  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • Frontiers in Immunology
  • The Journal of Infectious Diseases

Richard B. Kennedy has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS), an award received in 1966.

Best Publications

  • Multiple roles for CD4+ T cells in anti‐tumor immune responses

    Richard Kennedy;Esteban Celis

  • SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.

    Gregory A Poland;Inna G Ovsyannikova;Richard B Kennedy

  • Immunosenescence and human vaccine immune responses.

    Stephen N. Crooke;Inna G. Ovsyannikova;Gregory A. Poland;Richard B. Kennedy

  • Fine Mapping Causal Variants with an Approximate Bayesian Method Using Marginal Test Statistics.

    Wenan Chen;Beth R. Larrabee;Inna G. Ovsyannikova;Richard B. Kennedy

  • The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity.

    Inna G. Ovsyannikova;Iana H. Haralambieva;Stephen N. Crooke;Gregory A. Poland

  • Generation of Antitumor Immunity by Cytotoxic T Lymphocyte Epitope Peptide Vaccination, CpG-oligodeoxynucleotide Adjuvant, and CTLA-4 Blockade

    Eduardo Davila;Richard Kennedy;Esteban Celis

  • Smallpox and Vaccinia

    Richard B. Kennedy;J. Michael Lane;Donald A. Henderson;Gregory A. Poland

  • Personalized vaccinology: A review

    G.A. Poland;I.G. Ovsyannikova;R.B. Kennedy

  • Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses

    Stefan Avey;Foo Cheung;Damian Fermin

  • Development of vaccines against Zika virus.

    Gregory A Poland;Richard B Kennedy;Inna G Ovsyannikova;Ricardo Palacios

  • Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses.

    Stephen N. Crooke;Inna G. Ovsyannikova;Gregory A. Poland;Richard B. Kennedy

  • SARS-CoV-2 Vaccine Development: Current Status

    Gregory A. Poland;Inna G. Ovsyannikova;Stephen N. Crooke;Richard B. Kennedy

  • Systems biology approaches to new vaccine development.

    Ann L Oberg;Richard B Kennedy;Peter Li;Inna G Ovsyannikova

  • Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?

    Gregory A. Poland;Richard B. Kennedy;Inna G. Ovsyannikova

  • The immunology of smallpox vaccines.

    Richard B Kennedy;Inna G Ovsyannikova;Inna G Ovsyannikova;Robert M Jacobson;Gregory A Poland;Gregory A Poland

  • Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

    Gregory A. Poland;Richard B. Kennedy;Richard B. Kennedy;Brett A. McKinney;Brett A. McKinney;Inna G. Ovsyannikova;Inna G. Ovsyannikova

  • Direct Costimulation of Tumor-reactive CTL by Helper T Cells Potentiate Their Proliferation, Survival, and Effector Function

    Robert L. Giuntoli;Jun Lu;Hiroya Kobayashi;Richard Kennedy

  • Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.

    Stephen N. Crooke;Inna G. Ovsyannikova;Richard B. Kennedy;Gregory A. Poland

  • Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

    Gregory A. Poland;Inna G. Ovsyannikova;Richard B. Kennedy;Iana H. Haralambieva

  • Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations.

    Colin Pawlowski;Arjun Puranik;Hari Bandi;A. J. Venkatakrishnan

Frequent Co-Authors

Ann L. Oberg
Ann L. Oberg Mayo Clinic
V. Shane Pankratz
V. Shane Pankratz University of New Mexico
Daniel J. Schaid
Daniel J. Schaid Mayo Clinic
Esteban Celis
Esteban Celis Augusta University
Jun Lu
Jun Lu Zhejiang University
Andrew D. Badley
Andrew D. Badley Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, there are numerous complementary online degree options in related healthcare fields, especially nursing and advanced practice roles. Exploring dnp salary transparency can provide valuable insight into earning potential across different regions, helping students strategically plan their careers.

Many registered nurses (RNs) aim to advance to nurse practitioner roles through accelerated pathways. Programs highlighted in accelerated rn to np programs allow for a faster transition, which is ideal for those eager to apply immunology expertise in clinical settings.

For individuals without prior nursing experience interested in pivoting into healthcare, online rn programs for non nurses offer flexible learning options designed to build foundational knowledge efficiently.

Additionally, nurses who have already specialized as family nurse practitioners (FNPs) may consider obtaining acute care certification for fnp. This certification enables practitioners to work in more intensive care environments, aligning well with immunology-driven healthcare advancements.

Best Scientists Citing Richard B. Kennedy

Trending Scientists